How Immunotherapy Can Help Battle Cancer
7 Articles
7 Articles
New study shows how effective immunotherapy is at battling cancer
Some patients diagnosed with certain types of cancer may soon have the options to skip chemotherapy, radiation and surgery in favor of immunotherapy treatment, according to a new study published in the New England Journal of Medicine. NBC’s Dr. Natalie Azar joins TODAY to break down the findings.
How immunotherapy can help battle cancer
Using the body's own immune system to help fight cancer is called "immunotherapy." This Saturday is Immune to Cancer Day. In the FOX8 House Call, Brad Jones learns how immunotherapy is being used in the Piedmont Triad to treat several different types of cancer.
MUSC spinoff company touts better, safer cancer therapy but faces tough investment climate
Researchers at MUSC are using the immune system to fight cancer, and doing it safer, cheaper, and with a longer-lasting effect. A Mount Pleasant company is pushing that technology but is up against a bad business environment.
UMN researchers develop new treatment for late-stage GI cancers, initial trials prove promising results
A team of researchers at the University of Minnesota recently completed a human trial for a novel gene-editing treatment, which could provide hope to patients with late-stage gastrointestinal, or GI, cancers. The treatment boosts the immune system’s ability to fight cancerous tumors by modifying tumor-infiltrating lymphocytes, a type of white blood cell that can recognize and kill cancerous cells. Though similar approaches that work by activati…
Medicines that strengthen the immune system to fight disease show promising results in cancer treatment in early stages, a development prepared to expand its use and transform care for persistent diseases such as gastric and colon cancer.Immunotherapy treatments such as Opdivo, Bristol Myers Squibb, Imfinzi, AstraZeneca PLC, and Tecentriq, Roche Holding AG, have become the best sellers by increasing survival times in a number of advanced cancers.
Coverage Details
Bias Distribution
- 50% of the sources lean Left
To view factuality data please Upgrade to Premium